When Does the PD-1 Inhibitor Come Before the Hedgehog Inhibitor for Neoadjuvant BCC/CSCC?
Experts discuss when to use the PD-1 inhibitor cemiplimab vs the hedgehog inhibitor vismodegib as neoadjuvant treatment in non-melanoma skin cancers.
Source: onclive.com